Detailed immunotyping of immune-mediated inflammatory diseases (IMIDs) by investigating cellular and molecular biomarkers in blood and synovial fluid

Recruiting

• Conditions: arthritis; systemic inflammatory diseases; 10003816; 10023213

• Registration Number: NL-OMON55821
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 700

Inclusion Criteria

- patients with clinically suspected arthralgia or a diagnosis of an
immune-mediated inflammatory disease
- patients must be 18 years or older

Exclusion Criteria

- patients unable to give informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To identify immunological alterations in the PB and SF of patients with various<br /><br>forms of established or early forms of immune-mediated inflammatory diseases<br /><br>and to correlate these alterations with diagnosis, disease stage, prognosis,<br /><br>and treatment response and compare this to healthy controls. We thereby aim to<br /><br>identify and validate novel biomarkers that can be used for personalized<br /><br>medicine in IMIDs</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>